Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

Rhea-AI Summary

Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) has announced its participation in the 2024 Wells Fargo Healthcare Conference. The company's management will engage in a fireside chat on Wednesday, September 4, 2024, at 8:00 a.m. Eastern Time. Investors and interested parties can access a live webcast of Kiniksa's presentation through the Investors & Media section of the company's official website at www.kiniksa.com. For those unable to attend the live event, a replay will be made available on Kiniksa's website within approximately 48 hours after the presentation concludes.

News Market Reaction – KNSA

+1.48%

+1.48% Session move

In the trading session that priced this news, KNSA gained 1.48%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024 at 8:00 a.m. Eastern Time.

A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets, ARCALYST^®, abiprubart, and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.

ARCALYST^® is a registered trademark of Regeneron Pharmaceuticals, Inc.

Every Second Counts! ^®

Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com

Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com

FAQ

When is Kiniksa Pharmaceuticals (KNSA) presenting at the 2024 Wells Fargo Healthcare Conference?

Kiniksa Pharmaceuticals (KNSA) is presenting at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 8:00 a.m. Eastern Time.

How can I watch Kiniksa Pharmaceuticals' (KNSA) presentation at the Wells Fargo Healthcare Conference?

You can watch a live webcast of Kiniksa Pharmaceuticals' (KNSA) presentation through the Investors & Media section of the company's website at www.kiniksa.com.

Will there be a replay available of Kiniksa Pharmaceuticals' (KNSA) presentation at the 2024 Wells Fargo Healthcare Conference?

Yes, a replay of Kiniksa Pharmaceuticals' (KNSA) presentation will be available on the company's website within approximately 48 hours after the event.

What type of presentation will Kiniksa Pharmaceuticals (KNSA) give at the 2024 Wells Fargo Healthcare Conference?

Kiniksa Pharmaceuticals (KNSA) management will participate in a fireside chat at the 2024 Wells Fargo Healthcare Conference.